While biliverdin reductase-A (BVRA) protected against hepatic steatosis via PPARα activation [11], BVRA knockout mice on a HFD were glucose insensitive [11] and BVRA was lower in obese humans with insulin resistance [12]. This evidence concerns the gene BLVRA and fatty liver disease.